Literature DB >> 10408526

CACNA1A mutations: hemiplegic migraine, episodic ataxia type 2, and the others.

E Tournier-Lasserve.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10408526     DOI： 10.1212/wnl.53.1.3

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Long-term improvement of paroxysmal dystonic choreathetosis with acetazolamide.

Authors:  Veronique Michel; Florence Riant; Elisabeth Tournier-Lasserve; Dominique Guehl; Alain Lagueny; Bernard Bioulac; Pierre Burbaud
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

2.  The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes.

Authors:  S Restituito; R M Thompson; J Eliet; R S Raike; M Riedl; P Charnet; C M Gomez
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

3.  Paroxysmal dyskinesias in mice.

Authors:  Thomas L Shirley; Lekha M Rao; Ellen J Hess; H A Jinnah
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

4.  Paroxysmal dyskinesias in the lethargic mouse mutant.

Authors:  Zubair Khan; H A Jinnah
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

5.  Impact of depressed mood on neuropsychological status in temporal lobe epilepsy.

Authors:  S Paradiso; B P Hermann; D Blumer; K Davies; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

6.  A study to assess depression, its correlates and suicidal behaviour in epilepsy.

Authors:  Rajesh Jacob; M Suresh Kumar; R Rajkumar; V Palaniappun
Journal:  Indian J Psychiatry       Date:  2002-04       Impact factor: 1.759

7.  Genetic and metabolic characterization of insomnia.

Authors:  Hyo-Jeong Ban; Sang Cheol Kim; Jungmin Seo; Ho-Bum Kang; Jung Kyoon Choi
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.